SCOTT G. EWAN
Novartis (Switzerland)(CH)University College London(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Chemical Synthesis and Analysis, Immune Cell Function and Interaction, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models(1998)65 cited
- → Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist(1998)24 cited
- → Human Neurokinin-1 receptors, transiently transfected into Cos-7 cells, couple to simian G-proteins(1995)